Considering the preexisting immunity of patients to DENV, several reports described higher levels of IFN-α in patients undergoing primary infection compared to those with secondary DENV infections [77, 190, 192, 195], while other studies observed a similar expression of IFN-α levels in both types of infections [197, 198]. The gene discussed is IFNA2; the disease is infection.